Phase 3 Readout~month
Phase 3 Topline: A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of t
- Company
- Annexon, Inc. (ANNX)
- Indication
- Geographic Atrophy
Other upcoming events for ANNX
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.